MOVES- Chairman Ahmed Hegazy has resigned from his position as chairman of October Pharma, sources close to the company told Al Mal. Hegazy is also the chairman of ACDIMA Pharma, which owns a 30% stake in October. ACDIMA shareholders reportedly raised conflict of interest concerns arising from Hegazy simultaneously holding both positions. ACDIMA had initially nominated him to represent the company on the board, but appears to have changed its stance. In response to the shareholders’ concerns, the General Authority for Freezones and Investment restricted Hegazy from becoming a member on the board of any other companies, prompting him to step down from his position. October Pharma has not yet chosen who will replace the former chairman.
More from Enterprise
HSBC says it’s committed to commercial, investment banking in Egypt amid reports it’s inching closer to exiting retail franchise
“HSBC is very committed to Egypt as a strategic market…
EGX kicks off first day of futures trading on the EGX
The rollout includes 3- and 6-month future contracts tracking the…
Fiscal pressures mount for Egypt as CDS levels rise
Good morning, friends. The situation in Egypt remains calm as…
Bahrain’s Beban eyes Egypt launch with equity crowdfunding model
Mohamed Aboulnaga’s Foras AI raises stake as Beban seeks FRA…